First Time Loading...

Sorrento Therapeutics Inc
NASDAQ:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
NASDAQ:SRNE
Watchlist
Price: 0.3322 USD 8.92% Market Closed
Updated: Jun 1, 2024

Sorrento Therapeutics Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sorrento Therapeutics Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Sorrento Therapeutics Inc
NASDAQ:SRNE
PP&E Net
$138.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6B
CAGR 3-Years
7%
CAGR 5-Years
2%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.5B
CAGR 3-Years
4%
CAGR 5-Years
13%
CAGR 10-Years
7%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.2B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
22%

See Also

What is Sorrento Therapeutics Inc's PP&E Net?
PP&E Net
138.4m USD

Based on the financial report for Dec 31, 2022, Sorrento Therapeutics Inc's PP&E Net amounts to 138.4m USD.

What is Sorrento Therapeutics Inc's PP&E Net growth rate?
PP&E Net CAGR 1Y
9%

Over the last year, the PP&E Net growth was 9%.